<code id='749AA37308'></code><style id='749AA37308'></style>
    • <acronym id='749AA37308'></acronym>
      <center id='749AA37308'><center id='749AA37308'><tfoot id='749AA37308'></tfoot></center><abbr id='749AA37308'><dir id='749AA37308'><tfoot id='749AA37308'></tfoot><noframes id='749AA37308'>

    • <optgroup id='749AA37308'><strike id='749AA37308'><sup id='749AA37308'></sup></strike><code id='749AA37308'></code></optgroup>
        1. <b id='749AA37308'><label id='749AA37308'><select id='749AA37308'><dt id='749AA37308'><span id='749AA37308'></span></dt></select></label></b><u id='749AA37308'></u>
          <i id='749AA37308'><strike id='749AA37308'><tt id='749AA37308'><pre id='749AA37308'></pre></tt></strike></i>

          hotspot

          hotspot

          author:fashion    Page View:978
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          ALS treatment from Biogen, Ionis fails in study
          ALS treatment from Biogen, Ionis fails in study

          RubyWallauforSTATAplantousenewgenetictechniquestotreatnon-geneticformsofALSfailedinanearlystudy,Ioni

          read more
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more

          Free medical tuition alone isn't enough to close gaps in primary care

          In2018,NewYorkUniversitybecamethefirstU.S.medicalschooltogotuitionfree.Sincethen,ahandfulofothershav